Senores Pharma Q4 Results: Stock drops 5% on sequential earnings weakness
Senores Pharmaceuticals shares fell over 5% on Thursday despite the company reporting strong year-on-year growth in its March quarter earnings, as investors appeared concerned over sequential weakness in operating performance. The stock declined to ₹918.85 on the NSE after the earnings announcement. The company reported a 77.5% rise in net profit to ₹31.6 crore for…
